impassion130: immunotherapy for tnbc
Published 5 years ago • 390 plays • Length 2:30Download video MP4
Download video MP3
Similar videos
-
4:11
immunotherapy for tnbc: impassion130 & keynote-355
-
0:59
impassion130 data demonstrate clinical benefit for immunotherapy in metastatic tnbc
-
7:08
impassion130: results of atezolizumab plus nab-paclitaxel for frontline tnbc
-
8:42
chemoimmunotherapy in tnbc: the impassion130 trial
-
3:26
chemo-immunotherapy for tnbc
-
1:03
new directions in immunotherapy for improving outcomes in tnbc
-
4:47
tnbc: updated efficacy results from impassion130
-
1:30
emerging immunotherapy beyond checkpoint inhibitors for tnbc
-
2:33
applying impassion130 data to tnbc management
-
4:27
the impassion130 study in metastatic tnbc
-
1:16
the impassion130 trial in metastatic triple-negative breast cancer
-
1:34
strategies to improve the response to immunotherapy in tnbc
-
1:01
chemo-immunotherapy for tnbc
-
6:56
impassion130 trial data on pd-l1 tumors in tnbc
-
5:59
impassion130: atezolizumab and nab-paclitaxel in triple-negative breast cancer
-
2:44
impassion130: addressing immune-related aes in tnbc management
-
1:46
dr. schmid discusses the findings of impassion130 in tnbc
-
7:19
impassion130 trial: os updates in metastatic tnbc
-
2:07
keynote-355: pembrolizumab in triple-negative breast cancer